NASDAQ:RZLT - Rezolute Stock Price, News & Analysis

-0.05 (-25.00 %)
(As of 09/15/2019 04:00 PM ET)
Today's Range
Now: $0.15
50-Day Range N/A
52-Week Range
Now: $0.15
Volume10,100 shs
Average Volume20,955 shs
Market Capitalization$9.78 million
P/E RatioN/A
Dividend YieldN/A
Rezolute, Inc., a clinical stage biopharmaceutical company, specializes in the development of drug therapies for the treatment of patients with metabolic and orphan diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema; and RZ602, a product candidate that is in preclinical trial for the treatment of hereditary angioedema. It also develops AB101, a human recombinant insulin, which is in Phase I clinical trial for the treatment of patients with type 1 and type 2 diabetes mellitus. Rezolute, Inc. has a development and license agreement with ActiveSite Pharmaceuticals, Inc. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Industry, Sector and Symbol

Industry Biotechnology
Current SymbolNASDAQ:RZLT



Sales & Book Value

Annual SalesN/A



Market Cap$9.78 million
Next Earnings Date9/20/2019 (Estimated)
OptionableNot Optionable

Receive RZLT News and Ratings via Email

Sign-up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter.

Rezolute (NASDAQ:RZLT) Frequently Asked Questions

What is Rezolute's stock symbol?

Rezolute trades on the NASDAQ under the ticker symbol "RZLT."

When is Rezolute's next earnings date?

Rezolute is scheduled to release their next quarterly earnings announcement on Friday, September 20th 2019. View Earnings Estimates for Rezolute.

What price target have analysts set for RZLT?

1 brokerages have issued 1 year price targets for Rezolute's stock. Their forecasts range from $0.38 to $0.38. On average, they anticipate Rezolute's stock price to reach $0.38 in the next year. This suggests a possible upside of 153.3% from the stock's current price. View Analyst Price Targets for Rezolute.

What is the consensus analysts' recommendation for Rezolute?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rezolute in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rezolute.

Has Rezolute been receiving favorable news coverage?

Media stories about RZLT stock have trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rezolute earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Rezolute.

Who are some of Rezolute's key competitors?

Who are Rezolute's key executives?

Rezolute's management team includes the folowing people:
  • Mr. Nevan Charles Elam, CEO & Director (Age 52)
  • Dr. Hoyoung Huh, Founder, Chairman of Scientific Advisory Board & Bus. Dev. & Vice Chairman (Age 50)
  • Dr. Keith A. Vendola, Chief Financial Officer (Age 47)
  • Dr. Sankaram Mantripragada, Chief Scientific Officer (Age 59)
  • Mr. Michael R. Deperro, VP of Operations

How do I buy shares of Rezolute?

Shares of RZLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rezolute's stock price today?

One share of RZLT stock can currently be purchased for approximately $0.15.

How big of a company is Rezolute?

Rezolute has a market capitalization of $9.78 million. Rezolute employs 20 workers across the globe.View Additional Information About Rezolute.

What is Rezolute's official website?

The official website for Rezolute is

How can I contact Rezolute?

The company can be reached via phone at 650-206-4507.

MarketBeat Community Rating for Rezolute (NASDAQ RZLT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  15
MarketBeat's community ratings are surveys of what our community members think about Rezolute and other stocks. Vote "Outperform" if you believe RZLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RZLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/15/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel